US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 72.300
  • -0.960-1.31%
Close Apr 29 16:00 ET
  • 72.300
  • 0.0000.00%
Post 17:11 ET
7.62BMarket Cap-49520P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 22, 2024

Revenue(YoY)

132.10M

+50.34%
EPS(YoY)

-0.30

+33.33%

Strong Buy

Apr 24, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 159.397M--
--2024/Q1-- / 141.141M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--
Aug 3, 20232023/Q2110.792M / 106.815M--
May 4, 20232023/Q195.306M / 92.413M--
Mar 1, 20232022/Q487.869M / 86.966M--
Nov 3, 20222022/Q371.870M / 66.004M--
Aug 9, 20222022/Q255.579M / 48.625M--
May 10, 20222022/Q134.996M / 33.515M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 159.397M--
--2024/Q1-- / 141.141M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--
Aug 3, 20232023/Q2110.792M / 106.815M--
May 4, 20232023/Q195.306M / 92.413M--
Mar 1, 20232022/Q487.869M / 86.966M--
Nov 3, 20222022/Q371.870M / 66.004M--
Aug 9, 20222022/Q255.579M / 48.625M--
May 10, 20222022/Q134.996M / 33.515M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 24, 2024

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg